国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pyrococcus furiosus 30S ribosomal protein S19P (rps19p) CSB-YP848548FHW
CSB-EP848548FHW
CSB-BP848548FHW
CSB-MP848548FHW
CSB-EP848548FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 50S ribosomal protein L24P (rpl24p) CSB-YP848549FHW
CSB-EP848549FHW
CSB-BP848549FHW
CSB-MP848549FHW
CSB-EP848549FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 50S ribosomal protein L15P (rpl15p) CSB-YP848550FHW
CSB-EP848550FHW
CSB-BP848550FHW
CSB-MP848550FHW
CSB-EP848550FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus UPF0235 protein PF1765 (PF1765) CSB-YP848551FHW
CSB-EP848551FHW
CSB-BP848551FHW
CSB-MP848551FHW
CSB-EP848551FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Carbamoyl-phosphate synthase large chain (carB), partial CSB-YP848552FHW
CSB-EP848552FHW
CSB-BP848552FHW
CSB-MP848552FHW
CSB-EP848552FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Shikimate kinase (aroK) CSB-YP848553FHW
CSB-EP848553FHW
CSB-BP848553FHW
CSB-MP848553FHW
CSB-EP848553FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus N-acetyl-gamma-glutamyl-phosphate/N-acetyl-gamma-aminoadipyl-phosphate reductase (argC) CSB-YP848554FHW
CSB-EP848554FHW
CSB-BP848554FHW
CSB-MP848554FHW
CSB-EP848554FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus DNA-directed RNA polymerase subunit D (rpoD) CSB-YP848555FHW
CSB-EP848555FHW
CSB-BP848555FHW
CSB-MP848555FHW
CSB-EP848555FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Pyruvoyl-dependent arginine decarboxylase (pdaD) CSB-YP848556FHW
CSB-EP848556FHW
CSB-BP848556FHW
CSB-MP848556FHW
CSB-EP848556FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Type 2 DNA topoisomerase 6 subunit B (top6B), partial CSB-YP848557FHW
CSB-EP848557FHW
CSB-BP848557FHW
CSB-MP848557FHW
CSB-EP848557FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus DNA-directed RNA polymerase subunit A' (rpoA2) CSB-YP848558FHW
CSB-EP848558FHW
CSB-BP848558FHW
CSB-MP848558FHW
CSB-EP848558FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Dihydroorotate dehydrogenase B (NAD (+)), catalytic subunit (pyrD) CSB-YP848559FHW
CSB-EP848559FHW
CSB-BP848559FHW
CSB-MP848559FHW
CSB-EP848559FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus GMP synthase [glutamine-hydrolyzing] subunit B (guaAB) CSB-YP848560FHW
CSB-EP848560FHW
CSB-BP848560FHW
CSB-MP848560FHW
CSB-EP848560FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus UPF0212 protein PF1486 (PF1486) CSB-YP848561FHW
CSB-EP848561FHW
CSB-BP848561FHW
CSB-MP848561FHW
CSB-EP848561FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Arginine--tRNA ligase (argS), partial CSB-YP848562FHW
CSB-EP848562FHW
CSB-BP848562FHW
CSB-MP848562FHW
CSB-EP848562FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Threonine--tRNA ligase (thrS), partial CSB-YP848563FHW
CSB-EP848563FHW
CSB-BP848563FHW
CSB-MP848563FHW
CSB-EP848563FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus UPF0248 protein PF1300 (PF1300) CSB-YP848564FHW
CSB-EP848564FHW
CSB-BP848564FHW
CSB-MP848564FHW
CSB-EP848564FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Protein CrcB homolog (crcB), partial CSB-YP848565FHW1
CSB-EP848565FHW1
CSB-BP848565FHW1
CSB-MP848565FHW1
CSB-EP848565FHW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Ribulose bisphosphate carboxylase (rbcL) CSB-YP848566FHW
CSB-EP848566FHW
CSB-BP848566FHW
CSB-MP848566FHW
CSB-EP848566FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus tRNA pseudouridine synthase Pus10 (pus10) CSB-YP848567FHW
CSB-EP848567FHW
CSB-BP848567FHW
CSB-MP848567FHW
CSB-EP848567FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>